CASTLE BIOSCIENCES INC Income Statement
CSTL / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
CASTLE BIOSCIENCES INC reported $344M in revenue and $24M in net loss for FY2025. Revenue has grown at a 47.4% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $344.2M | $332.1M | $219.8M | $137.0M | $94.1M | $62.6M | $51.9M | $22.8M |
| Cost of Revenue | $71.0M | $60.2M | $45.0M | $32.0M | $15.8M | $9.7M | $7.3M | $5.3M |
| Gross Profit | - | - | - | - | - | $15.0M | $44.6M | $17.5M |
| SG&A Expense | $229.3M | $200.0M | $180.2M | $143.0M | $86.7M | $48.1M | $29.8M | $16.5M |
| R&D Expense | $51.9M | $52.0M | $53.6M | $44.9M | $29.6M | $13.3M | $7.4M | $4.9M |
| Operating Income | -$42.8M | $8.7M | -$68.0M | -$72.9M | -$40.1M | -$6.5M | $7.3M | -$3.8M |
| Interest Expense | - | - | $11.0K | $17.0K | $1.0K | $2.6M | $4.6M | $2.3M |
| Income Tax | -$5.4M | $3.3M | $101.0K | -$1.8M | -$8.7M | $84.0K | $72.0K | $9.0K |
| Net Income | -$24.2M | $18.2M | -$57.5M | -$67.1M | -$31.3M | -$10.3M | $5.3M | -$6.4M |
| EPS (Basic) | -$0.83 | $0.66 | -$2.58 | -$2.58 | -$1.24 | $0.35 | -$5.33 | -$5.33 |
| EPS (Diluted) | -$0.83 | $0.62 | -$2.58 | -$2.58 | -$1.24 | -$0.21 | -$5.33 | -$5.33 |
| Shares Outstanding | 29.7M | 28.5M | 26.6M | 26.6M | 25.4M | 17.1M | 1.9M | 1.9M |
| Gross Margin | - | - | - | - | - | 24.0% | 85.9% | 76.8% |
| Operating Margin | -12.4% | 2.6% | -30.9% | -53.2% | -42.6% | -10.4% | 14.1% | -16.8% |
| Profit Margin | -7.0% | 5.5% | -26.2% | -49.0% | -33.3% | -16.4% | 10.2% | -27.9% |